TY - JOUR
T1 - Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl
AU - Gaston, I.
AU - Johnson, K.J.
AU - Oda, T.
AU - Bhat, A.
AU - Reis, M.
AU - Langdon, Wallace
AU - Shen, L.
AU - Deininger, M.W.
AU - Druker, B.J.
PY - 2004
Y1 - 2004
N2 - Objectives. Cbl is one of the major tyrosine-phosphorylated proteins in Bcr-Abi-expressing cells. A direct association between the SH2 domain of Bcr-Abl and tyrosine-phosphorylated Cbl has been demonstrated. The purpose of this study was to determine if and how unphosphorylated Cbl and Bcr-Abl may associate.Methods. Interactions between Cbl and Ber-Abl were investigated in yeast two- and three-hybrid systems, gel overlay assays, and immuno precipitates from mammalian cells expressing wild-type and the Y177F mutant of Ber-Abl.Results. No direct interaction between Bcr-Abl and unphosphorylated Cbl was observed. Bcr-Abl did, however, associate with Grb2, an adaptor protein that binds tyrosine 177 of Bcr-Abl. Additionally, Grb2 interacted with Cbl. In a yeast three-hybrid assay, Grb2 mediated an interaction between Cb1 and Bcr-Abl that was dependent on a functional Grb2 binding site. This interaction was confirmed in vitro using purified proteins. In cells expressing Bcr-Abl with a mutation in the Grb2 binding site, binding of Cbl to Bcr-Abl was significantly reduced, but Cbl tyrosine phosphorylation was maintained. Imatinib treatment of these cells further reduced but did not abrogate Cbl binding, reflecting residual kinase activity.Conclusion. Multiple phosphotyrosine-dependent and -independent interactions stabilize the interaction between Cbl and Abl. Grb2 or another, yet unidentified, protein may mediate an initial interaction between Cbl and Bcr-Abl that is independent of Cbl tyrosine phosphorylation. Following this initial interaction, Cbl can then become tyrosine phosphorylated and interact with the SH2 domain of Ber-Abl, further stabilizing the complex. (C) 2004 International Society for Experimental Hematology. Published by Elsevier Inc.
AB - Objectives. Cbl is one of the major tyrosine-phosphorylated proteins in Bcr-Abi-expressing cells. A direct association between the SH2 domain of Bcr-Abl and tyrosine-phosphorylated Cbl has been demonstrated. The purpose of this study was to determine if and how unphosphorylated Cbl and Bcr-Abl may associate.Methods. Interactions between Cbl and Ber-Abl were investigated in yeast two- and three-hybrid systems, gel overlay assays, and immuno precipitates from mammalian cells expressing wild-type and the Y177F mutant of Ber-Abl.Results. No direct interaction between Bcr-Abl and unphosphorylated Cbl was observed. Bcr-Abl did, however, associate with Grb2, an adaptor protein that binds tyrosine 177 of Bcr-Abl. Additionally, Grb2 interacted with Cbl. In a yeast three-hybrid assay, Grb2 mediated an interaction between Cb1 and Bcr-Abl that was dependent on a functional Grb2 binding site. This interaction was confirmed in vitro using purified proteins. In cells expressing Bcr-Abl with a mutation in the Grb2 binding site, binding of Cbl to Bcr-Abl was significantly reduced, but Cbl tyrosine phosphorylation was maintained. Imatinib treatment of these cells further reduced but did not abrogate Cbl binding, reflecting residual kinase activity.Conclusion. Multiple phosphotyrosine-dependent and -independent interactions stabilize the interaction between Cbl and Abl. Grb2 or another, yet unidentified, protein may mediate an initial interaction between Cbl and Bcr-Abl that is independent of Cbl tyrosine phosphorylation. Following this initial interaction, Cbl can then become tyrosine phosphorylated and interact with the SH2 domain of Ber-Abl, further stabilizing the complex. (C) 2004 International Society for Experimental Hematology. Published by Elsevier Inc.
U2 - 10.1016/j.exphem.2003.09.018
DO - 10.1016/j.exphem.2003.09.018
M3 - Article
VL - 32
SP - 113
EP - 121
JO - Experimental Hematology
JF - Experimental Hematology
SN - 0301-472X
IS - NA
ER -